Literature DB >> 19002796

Role of oxygenation and vascularization in drug resistance.

J Mattern, M Volm.   

Abstract

Oxygenation status and tumor vascularization seem to be important factors in determining therapeutic effectiveness and patient prognosis. An abundance of data on tumor oxygenation and vascularization is available and it clearly shows that most human solid tumors are heterogeneously oxygenated and vascularized. They contain hypoxic regions. Such regions and areas of reduced vascularization can affect the response to a variety of drugs. Direct measurements of pO(2) and the vascular density in various types of tumors have, upon correlation of the data to therapeutic outcome, shown that low pO(2) values and low vascular density are associated with a decreased response to therapy. Therefore, oxygenation status and the extent of tumor vascularization may well be important factors contributing to the difficulty of successful therapy in certain types of tumors.

Entities:  

Year:  1998        PMID: 19002796      PMCID: PMC3449555          DOI: 10.1023/A:1008033326059

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  61 in total

1.  Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy.

Authors:  R A Gatenby; H B Kessler; J S Rosenblum; L R Coia; P J Moldofsky; W H Hartz; G J Broder
Journal:  Int J Radiat Oncol Biol Phys       Date:  1988-05       Impact factor: 7.038

2.  Drug resistance in Chinese hamster ovary cells during recovery from severe hypoxia.

Authors:  R E Wilson; P C Keng; R M Sutherland
Journal:  J Natl Cancer Inst       Date:  1989-08-16       Impact factor: 13.506

Review 3.  Proliferation-dependent cytotoxicity of anticancer agents: a review.

Authors:  F Valeriote; L van Putten
Journal:  Cancer Res       Date:  1975-10       Impact factor: 12.701

4.  Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck.

Authors:  M Nordsmark; M Overgaard; J Overgaard
Journal:  Radiother Oncol       Date:  1996-10       Impact factor: 6.280

5.  Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy.

Authors:  G Gasparini; M Barbareschi; P Boracchi; P Verderio; O Caffo; S Meli; P Dalla Palma; E Marubini; P Bevilacqua
Journal:  Cancer J Sci Am       Date:  1995 Jul-Aug

6.  Expression of resistance factors (P-glycoprotein, glutathione S-transferase-pi, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas.

Authors:  M Volm; M Kästel; J Mattern; T Efferth
Journal:  Cancer       Date:  1993-06-15       Impact factor: 6.860

Review 7.  The relevance of tumour pH to the treatment of malignant disease.

Authors:  J L Wike-Hooley; J Haveman; H S Reinhold
Journal:  Radiother Oncol       Date:  1984-12       Impact factor: 6.280

Review 8.  Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review.

Authors:  P Vaupel; F Kallinowski; P Okunieff
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

9.  Interrelationships between microvessel density, expression of VEGF and resistance to doxorubicin of non-small lung cell carcinoma.

Authors:  M Volm; R Koomägi; J Mattern
Journal:  Anticancer Res       Date:  1996 Jan-Feb       Impact factor: 2.480

10.  The effect of hypoxia on acquired drug resistance and response to epidermal growth factor in Chinese hamster lung fibroblasts and human breast-cancer cells in vitro.

Authors:  R Kalra; A M Jones; J Kirk; G E Adams; I J Stratford
Journal:  Int J Cancer       Date:  1993-06-19       Impact factor: 7.396

View more
  3 in total

1.  Synthesis of dihydronaphthalene analogues inspired by combretastatin A-4 and their biological evaluation as anticancer agents.

Authors:  Casey J Maguire; Zhi Chen; Vani P Mocharla; Madhavi Sriram; Tracy E Strecker; Ernest Hamel; Heling Zhou; Ramona Lopez; Yifan Wang; Ralph P Mason; David J Chaplin; Mary Lynn Trawick; Kevin G Pinney
Journal:  Medchemcomm       Date:  2018-08-24       Impact factor: 3.597

2.  Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp.

Authors:  Khalid O Alfarouk; Christian-Martin Stock; Sophie Taylor; Megan Walsh; Abdel Khalig Muddathir; Daniel Verduzco; Adil H H Bashir; Osama Y Mohammed; Gamal O Elhassan; Salvador Harguindey; Stephan J Reshkin; Muntaser E Ibrahim; Cyril Rauch
Journal:  Cancer Cell Int       Date:  2015-07-15       Impact factor: 5.722

Review 3.  Cell-Based Nanoparticles Delivery Systems for Targeted Cancer Therapy: Lessons from Anti-Angiogenesis Treatments.

Authors:  Paz de la Torre; María Jesús Pérez-Lorenzo; Álvaro Alcázar-Garrido; Ana I Flores
Journal:  Molecules       Date:  2020-02-07       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.